Preclinical Studies of a Novel Anti-Tumor Prodrug Therapy

被引：0
|
作者：
Wang, Jing-Hung [1 ]
Zhao, Ming [2 ]
Barak, Yoram [1 ]
Hoffman, Robert M. [2 ]
Matin, A. C. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] AntiCancer Inc, San Diego, CA USA
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
278
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [21] Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies
    Zuo, Shiyi
    Liu, Tian
    Li, Lingxiao
    Xu, Hezhen
    Guo, Jiayu
    Wang, Qing
    Yang, Yinxian
    He, Zhonggui
    Sun, Jin
    Sun, Bingjun
    CELL REPORTS MEDICINE, 2024, 5 (03)
  • [22] Enzymes in Nanomedicine for Anti-tumor Therapy
    Tong Zhou
    Shuaiqi Yuan
    Pinrong Qian
    Yuzhou Wu
    Chemical Research in Chinese Universities, 2023, 39 : 72 - 82
  • [23] Enzymes in Nanomedicine for Anti-tumor Therapy
    Zhou, Tong
    Yuan, Shuaiqi
    Qian, Pinrong
    Wu, Yuzhou
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2023, 39 (01) : 72 - 82
  • [24] Preclinical Candidate SYN608-a Novel PARG Inhibitor with Excellent Anti-tumor Activity
    Shi, S.
    Tang, X.
    He, H.
    Ge, C.
    Cui, Y.
    Xie, Y.
    Kan, C.
    Liu, S.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S134 - S134
  • [25] Chemopreventive and anti-tumor potential of vitamin E in preclinical breast cancer studies: A systematic review
    Coelho, Maria do Perpetuo Socorro de Sousa
    Pereira, Irislene Costa
    de Oliveira, Kynnara Gabriella Feitosa
    Oliveira, Iara Katryne Fonseca
    Rizzo, Marcia dos Santos
    de Oliveira, Victor Alves
    da Silva, Felipe Cavalcanti Carneiro
    Torres -Leal, Francisco Leonardo
    Sousa, Joao Marcelo de Castro e
    CLINICAL NUTRITION ESPEN, 2023, 53 : 60 - 73
  • [26] Preclinical development of a novel oral multitargeted kinase inhibitor with potent in vivo anti-tumor activity
    Beaulieu, Normand
    Dupont, Isabelle
    Hannah Nguyen
    Carole, Beaulieu
    Ste-Croix, Helene
    Robert, Marie-France
    Lefebvre, Sylvain
    Lu, Ai Hua
    Dubay, Maria
    Rahil, Gabi
    Wang, James
    Mannion, Michael
    Raeppel, Stephane
    Saavedra, Oscar
    Claridge, Stephen
    Isakovic, Lubo
    Zhan, Lijie
    Gaudette, Frederic
    Zhou, Nancy
    Nantel, Miguel
    Raeppel, Franck
    Vaisburg, Arkadii
    Besterman, Jeffrey
    Maroun, Christiane
    CANCER RESEARCH, 2009, 69
  • [27] STUDIES ON MACROMOMYCIN, AN ANTI-TUMOR PROTEIN
    IM, WB
    CHIANG, CK
    MONTGOMERY, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1978, 253 (09) : 3259 - 3264
  • [28] STUDIES WITH THE ANTI-TUMOR AGENT SPIROGERMANIUM
    WOOLLEY, PV
    MAGUIRE, P
    FOX, P
    HOTH, D
    SLAVIK, M
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 436 - 436
  • [29] Preclinical characterization of GSK532, a novel STING agonist with potent anti-tumor activity
    Yang, Jingsong
    Adam, Michael
    Clemens, Jim
    Creech, Katrina
    Schneck, Jess
    Pasikanti, Kishore
    Jean-Luc Tran
    Joglekar, Devika
    Hopson, Chris
    Pesiridis, Scott
    Ramanjulu, Joshi
    Lian, Yiqian
    Adams, Jerry L.
    Smothers, James
    Hoos, Axel
    CANCER RESEARCH, 2018, 78 (13)
  • [30] NOVEL ANTI-TUMOR ANTIBIOTICS, TETROCARCINS
    TOMITA, F
    TAMAOKI, T
    SHIRAHATA, K
    KASAI, M
    MORIMOTO, M
    OHKUBO, S
    MINEURA, K
    ISHII, S
    JOURNAL OF ANTIBIOTICS, 1980, 33 (06): : 668 - 670
12345